Catheter Precision (VTAK) Liabilities from Discontinued Operations (2020)
Catheter Precision (VTAK) posted quarterly Liabilities from Discontinued Operations of 2102000.0 for Q4 2020.
Catheter Precision (VTAK) Liabilities from Discontinued Operations (2020) Analysis & Trends
Catheter Precision (VTAK) has reported Liabilities from Discontinued Operations for 1 consecutive years, with 2102000.0 the latest figure, recorded in Q4 2020.
- In Q4 2020, Liabilities from Discontinued Operations changed N/A year-over-year to 2102000.0; the TTM figure through Dec 2020 stood at 2102000.0 (changed N/A YoY), while the FY2020 annual figure was 2102000.0, changed N/A from the prior year.
- Liabilities from Discontinued Operations steadied at 2102000.0 in Q4 2020 per VTAK's latest filing.
- Across five years, Liabilities from Discontinued Operations topped out at 2102000.0 in Q4 2020 and bottomed at 2102000.0 in Q4 2020.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn |
| 10 | Catheter Precision | 564,834.50 | -1.27 Mn | 98,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2020 | 2.10 Mn |
| Dec 31, 2020 | 2.10 Mn |